Stocks
HighTower Advisors Boosts Stake in Merck & Co., Inc. Amidst Analyst Upgrades
HighTower Advisors LLC increased its stake in Merck & Co., Inc. (NYSE:MRK) by 1.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 3,679,920 shares of the company's stock after acquiring an additional 44,516 shares during the period.
Merck & Co., Inc.'s quarterly earnings results were released on Tuesday, August 4th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.26) by $0.13.
The business had revenue of $16.61 billion for the quarter, compared to the consensus estimate of $16.37 billion. Merck & Co., Inc. has set its FY 2026 guidance at 2.660-2.760 EPS.